Literature DB >> 11148008

Historical perspective of foamy virus epidemiology and infection.

C D Meiering1, M L Linial.   

Abstract

Foamy viruses (FV) are complex retroviruses which are widespread in many species. Despite being discovered over 40 years ago, FV are among the least well characterized retroviruses. The replication of these viruses is different in many interesting respects from that of all other retroviruses. Infection of natural hosts by FV leads to a lifelong persistent infection, without any evidence of pathology. A large number of studies have looked at the prevalence of primate foamy viruses in the human population. Many of these studies have suggested that FV infections are prevalent in some human populations and are associated with specific diseases. More recent data, using more rigorous criteria for the presence of viruses, have not confirmed these studies. Thus, while FV are ubiquitous in all nonhuman primates, they are only acquired as rare zoonotic infections in humans. In this communication, we briefly discuss the current status of FV research and review the history of FV epidemiology, as well as the lack of pathogenicity in natural, experimental, and zoonotic infections.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11148008      PMCID: PMC88968          DOI: 10.1128/CMR.14.1.165-176.2001

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  127 in total

1.  Replication of a foamy virus mutant with a constitutively active U3 promoter and deleted accessory genes.

Authors:  T Schenk; J Enssle; N Fischer; A Rethwilm
Journal:  J Gen Virol       Date:  1999-07       Impact factor: 3.891

2.  No evidence of spumaretrovirus infection markers in 19 cases of De Quervain's thyroiditis.

Authors:  M C Debons-Guillemin; J Valla; J Gazeau; J Wybier-Franqui; M L Giron; M E Toubert; M Canivet; J Périés
Journal:  AIDS Res Hum Retroviruses       Date:  1992-09       Impact factor: 2.205

3.  A sorting motif localizes the foamy virus glycoprotein to the endoplasmic reticulum.

Authors:  P A Goepfert; K L Shaw; G D Ritter; M J Mulligan
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

4.  Detection of immunological tolerance to bovine spumavirus (BSV) with evidence for salivary excretion and spread of BSV from the tolerant animal.

Authors:  I G Kertayadnya; R H Johnson; I Abher; G W Burgess
Journal:  Vet Microbiol       Date:  1988-01       Impact factor: 3.293

5.  Antigenic relationship of human foamy virus to the simian foamy viruses.

Authors:  G J Nemo; P W Brown; C J Gibbs; D C Gajdusek
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

6.  Foamy virus particle formation.

Authors:  N Fischer; M Heinkelein; D Lindemann; J Enssle; C Baum; E Werder; H Zentgraf; J G Müller; A Rethwilm
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Lymphocytes are the major reservoir for foamy viruses in peripheral blood.

Authors:  D von Laer; D Neumann-Haefelin; J L Heeney; M Schweizer
Journal:  Virology       Date:  1996-07-01       Impact factor: 3.616

8.  Absence of serological evidence for foamy virus infection in patients with amyotrophic lateral sclerosis.

Authors:  M Rösener; H Hahn; M Kranz; J Heeney; A Rethwilm
Journal:  J Med Virol       Date:  1996-03       Impact factor: 2.327

9.  No evidence for spumavirus or oncovirus infection in relapsing-remitting multiple sclerosis.

Authors:  A Svenningsson; J Lycke; B Svennerholm; S Gronowitz; O Andersen
Journal:  Ann Neurol       Date:  1992-11       Impact factor: 10.422

10.  Prevalence of human foamy virus-related sequences in the Korean population.

Authors:  H Lee; S Kim; M Kang; W Kim; B Cho
Journal:  J Biomed Sci       Date:  1998 Jul-Aug       Impact factor: 8.410

View more
  85 in total

1.  Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors.

Authors:  Grant Trobridge; David W Russell
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

2.  Protease-dependent uncoating of a complex retrovirus.

Authors:  Jacqueline Lehmann-Che; Marie-Lou Giron; Olivier Delelis; Martin Löchelt; Patricia Bittoun; Joelle Tobaly-Tapiero; Hugues de Thé; Ali Saïb
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Basic residues in the foamy virus Gag protein.

Authors:  Daniel Matthes; Tatiana Wiktorowicz; Juliane Zahn; Jochen Bodem; Nicole Stanke; Dirk Lindemann; Axel Rethwilm
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

4.  Expanded tissue targets for foamy virus replication with simian immunodeficiency virus-induced immunosuppression.

Authors:  S M Murray; L J Picker; M K Axthelm; M L Linial
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 5.  The role of RNAi and microRNAs in animal virus replication and antiviral immunity.

Authors:  Jennifer L Umbach; Bryan R Cullen
Journal:  Genes Dev       Date:  2009-05-15       Impact factor: 11.361

6.  Identification of recombination in the envelope gene of simian foamy virus serotype 2 isolated from Macaca cyclopis.

Authors:  Teresa A Galvin; Imran A Ahmed; Muhammad Shahabuddin; Theodore Bryan; Arifa S Khan
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

7.  Similar patterns of infection with bovine foamy virus in experimentally inoculated calves and sheep.

Authors:  Magdalena Materniak; Torsten Hechler; Martin Löchelt; Jacek Kuzmak
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

8.  Identification of novel, highly expressed retroviral microRNAs in cells infected by bovine foamy virus.

Authors:  Adam W Whisnant; Timo Kehl; Qiuying Bao; Magdalena Materniak; Jacek Kuzmak; Martin Löchelt; Bryan R Cullen
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

9.  Sensitive assays for simian foamy viruses reveal a high prevalence of infection in commensal, free-ranging Asian monkeys.

Authors:  Lisa Jones-Engel; Katherine A Steinkraus; Shannon M Murray; Gregory A Engel; Richard Grant; Nantiya Aggimarangsee; Benjamin P Y-H Lee; Cynthia May; Michael A Schillaci; Chaleamchat Somgird; Tulyawat Sutthipat; Lucia Vojtech; JianYuan Zhao; Maxine L Linial
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

10.  Virus-specific host miRNAs: antiviral defenses or promoters of persistent infection?

Authors:  Vinay S Mahajan; Adam Drake; Jianzhu Chen
Journal:  Trends Immunol       Date:  2008-12-06       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.